Kristin Danielle Kennedy, NP
Nurse Practitioner · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kristin Danielle Kennedy’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$2,481
Medicare paid this office $2,481 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit | 29 | $648 | $19 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 73 · Health risk score 0.77. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 55%.
The office billed $12,375, Medicare allowed $3,784 and paid $2,481; for 75 services of 3 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 75 | 73 | 0.77 | $12,375 | $2,481 |
| 2023 | 52 | 164 | 73 | 0.69 | $23,965 | $6,097 |
| 2022 | 61 | 186 | 73 | 0.96 | $32,241 | $7,343 |
| 2021 | 38 | 93 | 72 | 0.99 | $13,049 | $3,436 |
| 2020 | 19 | 31 | 71 | 0.85 | $5,346 | $1,180 |
| 2017 | 15 | 15 | 77 | 0.90 | $2,202 | $1,365 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit | 45 | $1,931 | $24 |
2022: 2 services
| Short return visit | 43 | $1,562 | $22 |
| Short return visit (20+ min) | 11 | $661 | $51 |
2021: 1 service
| Short return visit | 29 | $1,338 | $26 |
2020: 1 service
| Short return visit | 12 | $318 | $18 |
2017: 1 service
| New patient visit (45+ min) | 13 | $1,270 | $98 |
Drugs they prescribed that Part D paid
$20,213
Pharmacies billed $20,213 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 306) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
289 generic and 17 brand-name prescriptions · $20,213 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 38 | $5,140 | $135 |
| Yuvafem | 14 | $2,457 | $176 |
| Clobetasol Propionate | 75 | $2,133 | $28 |
| Betamethasone Dipropionate | 29 | $1,239 | $43 |
| Dexamethasone | 11 | $226 | $21 |
See all 8 drugs
| Estradiol | 38 | $5,140 | $135 |
| Yuvafem | 14 | $2,457 | $176 |
| Clobetasol Propionate | 75 | $2,133 | $28 |
| Betamethasone Dipropionate | 29 | $1,239 | $43 |
| Dexamethasone | 11 | $226 | $21 |
| Triamcinolone Acetonide | 31 | $149 | $5 |
| Hydrocortisone | 15 | $62 | $4 |
| Hydroxyzine | 12 | $52 | $4 |
Year by year
| 2024 | 306 | 114 | 0% (0) | 6% | $20,213 |
| 2023 | 457 | 168 | 0% (0) | 4% | $26,454 |
| 2022 | 629 | 198 | None | 8% | $165,534 |
| 2021 | 607 | 207 | None | 6% | $76,772 |
| 2020 | 530 | 180 | 0% (0) | 8% | $34,369 |
| 2019 | 478 | 179 | 0% (0) | 15% | $38,249 |
| 2018 | 585 | 202 | None | 15% | $76,276 |
| 2017 | 413 | 179 | None | 13% | $100,382 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Estradiol | 37 | $5,139 | $139 |
| Yuvafem | 20 | $4,141 | $207 |
| Clobetasol Propionate | 112 | $3,476 | $31 |
| Betamethasone Dipropionate | 21 | $1,570 | $75 |
| Dexamethasone | 30 | $919 | $31 |
| Triamcinolone Acetonide | 69 | $701 | $10 |
| Nystatin-Triamcinolone | 16 | $616 | $39 |
| Nystatin | 12 | $356 | $30 |
| Ketoconazole | 21 | $322 | $15 |
| Hydrocortisone | 17 | $79 | $5 |
2022: 17 drugs
| Estradiol | 65 | $10,425 | $160 |
| Clobetasol Propionate | 83 | $4,492 | $54 |
| Yuvafem | 22 | $4,112 | $187 |
| Betamethasone Dipropionate | 18 | $1,491 | $83 |
| Triamcinolone Acetonide | 91 | $1,365 | $15 |
| Betamethasone Diprop Augmented | 12 | $1,219 | $102 |
| Hydroxychloroquine Sulfate | 12 | $935 | $78 |
| Ketoconazole | 42 | $723 | $17 |
| Metronidazole | 12 | $645 | $54 |
| Dexamethasone | 24 | $631 | $26 |
| Gabapentin | 18 | $576 | $32 |
| Nystatin | 13 | $397 | $31 |
| Hydroxyzine | 18 | $396 | $22 |
| Lidocaine-Prilocaine | 13 | $168 | $13 |
| Finasteride | 14 | $89 | $6 |
| Fluconazole | 17 | $85 | $5 |
| Hydrocortisone | 13 | $79 | $6 |
2021: 19 drugs
| Estradiol | 56 | $8,602 | $154 |
| Yuvafem | 14 | $2,861 | $204 |
| Clobetasol Propionate | 84 | $2,687 | $32 |
| Betamethasone Dipropionate | 17 | $1,396 | $82 |
| Valacyclovir | 13 | $1,210 | $93 |
| Betamethasone Diprop Augmented | 16 | $1,159 | $72 |
| Clindamycin Phosphate | 13 | $1,072 | $82 |
| Fluocinonide | 19 | $935 | $49 |
| Desonide | 11 | $899 | $82 |
| Gabapentin | 24 | $800 | $33 |
| Triamcinolone Acetonide | 80 | $625 | $8 |
| Metronidazole | 13 | $539 | $41 |
| Dexamethasone | 23 | $399 | $17 |
| Ketoconazole | 29 | $397 | $14 |
| Hydroxyzine | 25 | $383 | $15 |
| Hydrocortisone | 16 | $292 | $18 |
| Finasteride | 22 | $181 | $8 |
| Nystatin | 11 | $155 | $14 |
| Fluconazole | 15 | $68 | $5 |
2020: 15 drugs
| Estradiol | 47 | $10,411 | $222 |
| Premarin | 14 | $5,482 | $392 |
| Betamethasone Diprop Augmented | 28 | $2,702 | $97 |
| Yuvafem | 11 | $2,669 | $243 |
| Clobetasol Propionate | 77 | $2,662 | $35 |
| Fluocinonide | 13 | $918 | $71 |
| Metronidazole | 12 | $767 | $64 |
| Ketoconazole | 42 | $610 | $15 |
| Desonide | 11 | $579 | $53 |
| Triamcinolone Acetonide | 70 | $567 | $8 |
| Gabapentin | 21 | $468 | $22 |
| Valacyclovir | 12 | $405 | $34 |
| Nystatin | 22 | $317 | $14 |
| Acyclovir | 20 | $178 | $9 |
| Hydroxyzine | 11 | $134 | $12 |
2019: 15 drugs
| Premarin | 23 | $8,717 | $379 |
| Estradiol | 33 | $6,507 | $197 |
| Clobetasol Propionate | 79 | $4,730 | $60 |
| Yuvafem | 19 | $4,175 | $220 |
| Valacyclovir | 17 | $1,240 | $73 |
| Metronidazole | 18 | $1,209 | $67 |
| Betamethasone Dipropionate | 12 | $808 | $67 |
| Dexamethasone | 12 | $801 | $67 |
| Triamcinolone Acetonide | 62 | $591 | $10 |
| Betamethasone Valerate | 16 | $561 | $35 |
| Ketoconazole | 31 | $483 | $16 |
| Nystatin | 14 | $246 | $18 |
| Gabapentin | 11 | $230 | $21 |
| Finasteride | 12 | $81 | $7 |
| Hydrocortisone | 12 | $56 | $5 |
2018: 17 drugs
| Clobetasol Propionate | 124 | $11,136 | $90 |
| Premarin | 22 | $7,960 | $362 |
| Yuvafem | 30 | $6,954 | $232 |
| Estradiol | 26 | $5,764 | $222 |
| Metronidazole | 24 | $1,507 | $63 |
| Fluocinonide | 19 | $1,349 | $71 |
| Dexamethasone | 28 | $1,342 | $48 |
| Desonide | 12 | $890 | $74 |
| Triamcinolone Acetonide | 50 | $775 | $15 |
| Methotrexate | 12 | $650 | $54 |
| Hydroxyzine | 29 | $538 | $19 |
| Lidocaine | 17 | $525 | $31 |
| Betamethasone Valerate | 18 | $405 | $22 |
| Nystatin | 19 | $280 | $15 |
| Ketoconazole | 21 | $273 | $13 |
| Fluconazole | 14 | $81 | $6 |
| Hydrocortisone | 16 | $67 | $4 |
2017: 10 drugs
| Clobetasol Propionate | 86 | $10,122 | $118 |
| Premarin | 17 | $5,793 | $341 |
| Estrace | 18 | $5,159 | $287 |
| Fluocinonide | 20 | $2,038 | $102 |
| Desonide | 13 | $1,164 | $90 |
| Triamcinolone Acetonide | 51 | $529 | $10 |
| Hydroxyzine | 21 | $379 | $18 |
| Nystatin | 21 | $374 | $18 |
| Dexamethasone | 15 | $362 | $24 |
| Hydrocortisone | 15 | $80 | $5 |
Money from drug and device companies
$15 in 2023
A payment is not proof that care is biased.
| Pfizer | Cibinqo | $15 | 1 payment
|
See the published payment
| Pfizer | Education · 2023-05-10 | Cibinqo | $15 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1396289070
- Licence
- CA 95005266
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-12-14
- NPI last updated
- 2023-03-17
- NPI record certified
- 2023-03-17
This is when the NPI record was last certified, not a medical board exam.